Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis
The use of intravenous antibiotic formulations delivered by inhalation is controversial. Tolerance can be an issue and some treatment guidelines discourage this route of administration if the same antibiotic is available in an inhalation formulation. This was a retrospective, observational, single-c...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universidad Europea (UEM) |
| Repositorio: | ABACUS. Repositorio de Producción Científica |
| Idioma: | inglés |
| OAI Identifier: | oai:dnet:abacusreposi::949fa62d56c0f4e9841e4506f169f51f |
| Acceso en línea: | https://hdl.handle.net/11268/17080 |
| Access Level: | acceso abierto |
| Palabra clave: | Medicina Antibacterianos Infecciones del Sistema Respiratorio Tolerancia a Medicamentos Medicamento Aparato respiratorio Investigación médica Goal 3: Ensure healthy lives and promote well-being for all at all ages |
| Sumario: | The use of intravenous antibiotic formulations delivered by inhalation is controversial. Tolerance can be an issue and some treatment guidelines discourage this route of administration if the same antibiotic is available in an inhalation formulation. This was a retrospective, observational, single-center study comparing tolerance to three antibiotics delivered by nebulization (intravenous formulations of ampicillin and gentamicin, and an inhalation formulation of colistimethate sodium) in patients with bronchial infection (BI), chronic bronchial infection (CBI), and/or recurrent respiratory infections. The study also aimed to identify factors potentially associated with tolerability. |
|---|